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Over the period 1989–2003, the incidence of cervical adenocarcinoma (n¼1615) was stable whereas that of cervical
adenocarcinoma in situ (n¼1884) significantly decreased (P¼0.008), mainly caused by adenocarcinoma in situ lesions with a
concurrent squamous dysplasia.
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Adenocarcinoma (AC) and adenocarcinoma in situ (ACIS) of the
uterine cervix are rare diseases with an incidence of 1.2 per 100000
women per year for AC (http://www.oncoline.nl). The incidences
of both have increased during the last three decades, especially in
women under the age of 40 years (Zheng et al, 1996; Vizcaino et al,
1998; Bergstrom et al, 1999; Plaxe and Saltzstein, 1999; Smith et al,
2000; Liu et al, 2001; Sasieni and Adams, 2001; Visioli et al, 2004;
Wang et al, 2004; Bray et al, 2005). This contrasts with the decrease
in squamous cell carcinoma (SCC) since the introduction of
screening programmes (Bergstrom et al, 1999; Ronco et al, 2005;
Kyndi et al, 2006). Studies have shown that Pap smears are less
sensitive in detecting precursor lesions of AC than those of SCC
(Etherington and Luesley, 2001; Schoolland et al, 2002; Kalir et al,
2005). This makes the incidence of AC less likely to be influenced
by screening (Nieminen et al, 1995; Bergstrom et al, 1999).
Adenocarcinoma in situ is generally considered a precursor
lesion for AC (Kurian and al-Nafussi, 1999; Zaino, 2002), but
whether glandular precursor lesions develop in a manner similar
to squamous lesions, that is from mild via moderate to severe
atypia, is still under discussion (Brown and Wells, 1986; Hitchcock
et al, 1993; Goldstein et al, 1998).
We examined the incidence of AC and ACIS to see whether a
change in AC incidence is preceded by a similar change in ACIS,
especially in young women.
PATIENTS AND METHODS
Data concerning 2075 cases of ACIS/severe atypia registered
between 1 January 1992 and 31 December 2003 in the Netherlands
were collected via PALGA, the nationwide Netherlands database
of histo- and cytopathology (Casparie et al, 2007). This database
had national coverage from 1992. In total, 191 individuals were
excluded: 96 individuals who developed an adenocarcinoma of
cervical, endometrial, ovarian, or tubal origin within 6 months of
ACIS diagnosis, and another 95 individuals with the cytological
diagnosis of ACIS/severe glandular atypia not confirmed histolo-
gically. A total of 1884 women were included in the study.
Data concerning the incidence of AC were obtained from the
nationwide Netherlands Cancer Registry (Association of Compre-
hensive Cancer Centres), which was set up in 1989, and cases of AC
during the years 1989–2003 were retrieved (1615 patients). The
population data for the Netherlands for calculating European
standardised rates (ESRs) were obtained from the database of
Statistics Netherlands (http://www.cbs.nl/).
The incidence of AC and that of ACIS were calculated per 100000
person years (ESR). Age was categorised into 15-year strata as
follows: 15–29, 30–44, 45–59 and 460 years. To avoid small
numbers, 3-year groupings of the years from 1989 to 2003 were used.
Trends in incidence rates were examined by calculating the estimated
annual per cent change (EAPC). Using a univariate general linear
model, statistical differences between the incidences over time were
calculated. A significance level of Po0.05 was chosen.
RESULTS
The mean age of patients with ACIS was 37.8 years (range 17–93):
36.7 (s.d. 8.39) years for patients with a concurrent squamous
lesion, compared to 39.3 (s.d. 9.75) years for patients without a
concurrent squamous lesion (Po0.001). In patients with ACIS,
1078 patients (57%) had a concurrent squamous dysplasia: 92
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ypatients had atypical squamous cells, 112 patients had mild dysplasia,
152 patients had moderate dysplasia, 421 patients had severe
dysplasia and 301 patients had squamous cell carcinoma in situ.
Figure 1A shows the overall incidence of AC and ACIS over time.
The overall incidence of AC remained unchanged (P¼0.402),
whereas the overall incidence of ACIS decreased significantly
(P¼0.008). In Figure 1B–E, the age-standardised incidences of AC
and ACIS are shown for different age groups. A significant
decrease in ACIS incidence was found for the age groups 15–29
and 45–59. A significant decrease in AC incidence was found for
the age groups over 60 years of age. No significant increase was
found in AC incidence in women aged 15–29 years. In Figure 1F,
the incidence of ACIS subdivided between patients with and
without concurrent squamous dysplasia is shown for patients
eligible for the screening programme (30–59 years of age). In the
group of patients with a squamous dysplasia, a significant decrease
is seen (P¼0.006), whereas in the patients without concurrent
squamous dysplasia, the decrease is not significant (P¼0408).
DISCUSSION
This nationwide study in the Netherlands shows a significant
decrease in the incidence of ACIS but an unchanged incidence of
AC. Moreover, the decrease in the incidence of ACIS is mainly
caused by ACIS lesions with a concurrent squamous dysplasia. The
only two previous studies of AC and ACIS trends, both in the
United States, found an increase in the incidence of ACIS without a
significant change in AC incidence over a 20-year period (Plaxe
and Saltzstein, 1999; Wang et al, 2004).
This stable pattern in AC incidence accords with an earlier
report from the Netherlands (Bulk et al, 2005). However, in
contrast to that study, no significant increase was seen in AC
incidence in young patients. We used the same database but
extended the analysis to an additional 5 years, making short-term
fluctuations in AC incidence less important.
This unchanged AC incidence contrasts with the incidence rates
reported from other countries where it is rising (Zheng et al, 1996;
Vizcaino et al, 1998; Bergstrom et al, 1999; Plaxe and Saltzstein,
1999; Smith et al, 2000; Liu et al, 2001; Sasieni and Adams, 2001;
Visioli et al, 2004; Wang et al, 2004; Bray et al, 2005). However, a
stable pattern has been reported more often (Vizcaino et al, 1998;
Chan et al, 2003; Bulk et al, 2005), although a decreasing incidence
has also been recorded (Vizcaino et al, 1998; Bray et al, 2005;
Howlett et al, 2007). Studies covering the years after 1995 more
often found a decrease in AC incidence after an earlier increase; for
example, Howlett et al (2007) found an increase in AC incidence
from 1981 to 1995 and a decrease in incidence from 1995 to 2001.
This was attributed to the change in the sampling device used; the
endocervical brush was introduced to replace the spatula that
focused only on the sampling of squamous cells. In a study of the
screening history and risk of AC, it was concluded that AC
incidence should begin to decline in the current decade among
screened women (Mitchell et al, 2003). Our study included data
from 1989 to 2003, the second study to incorporate years after 2000
(Howlett et al, 2007).
The significant decrease of ACIS incidence in this study
contrasts with two other studies describing an increase, mainly
in patients under age 40 years (Plaxe and Saltzstein, 1999; Wang
et al, 2004). In the light of the increasing prevalence of HPV and
sexually transmitted infections in young women due to younger
ages of first intercourse (http://www.rivm.nl), the decrease in ACIS
incidence is rather surprising and contrasts with the increasing
incidence of other HPV-related lesions like vulvar intraepithelial
neoplasia (Jones et al, 1997; Iversen and Tretli, 1998; Joura et al,
2000). The decrease in ACIS incidence was mainly caused by ACIS
lesions with a concurrent squamous dysplasia. In the last few
years, much attention has been paid to the detection and treatment
of CIN lesions in the prevention of SCC. Treatment of these
patients with CIN may have caused removal or prevention of the
ACIS lesion. The significantly younger age of patients with ACIS
and concurrent squamous dysplasia could mean that lesions with
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Figure 1 (A) Total age standardised incidences for ACIS (1992–2003) and AC (1989–2003). (B–E) Age standardised incidence for ACIS (1992–
2003) and AC (1989–2003) for patients of different years of age. (F) Age standardised incidence for ACIS, subdivided between ACIS with and without a
concurrent squamous dysplasia. (A–E) ACIS incidence is indicated with a bold line, AC incidence with a dotted line. (F) ACIS with concurrent squamous
dysplasia is indicated with a bold line, without squamous dysplasia with the dotted line.
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than solitary ACIS lesions are. Alternatively, the difference in ACIS
with and without a squamous dysplasia may reflect a decline over
time in the level of detail of histopathological reporting. In this
study, 57% of ACIS lesions had a concurrent squamous dysplasia,
a proportion according with other studies (Colgan and Lickrish,
1990; Anciaux et al, 1997; Casper et al, 1997; Bekkers et al, 2003).
The decrease in ACIS incidence was mostly seen in the 15–29
and 45–59 years age groups, the former outside the ages of 30–60
years in the screening programme in the Netherlands. The
decrease may be the result of a general decrease in opportunistic
screening in this age group. At ages 30–44, when no significant
decrease in ACIS was seen, the first cervical smear in the screening
programme is performed. Because of the first screening effect, the
incidence in this age group is not likely to decrease. The women
aged 45–59 probably had an earlier cervical smear, which may
have led to an ACIS decrease.
Others report that AC incidence might not be influenced by
screening (Nieminen et al, 1995; Bergstrom et al, 1999). The
decrease of ACIS in the age group 45–59 and of AC over age 60
years in this study may reflect detection of ACIS lesions in the
screened population, but further studies will be required over long
time periods.
The present study finds a decrease in ACIS incidence over time,
mainly due to lesions with a concurrent squamous dysplasia, but
not (yet) reflected by a decrease in AC incidence.
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